Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
暂无分享，去创建一个
W. Wilson | S. Steinberg | A. LaCasce | J. Friedberg | E. Jaffe | S. Pittaluga | K. Dunleavy | N. Bartlett | S. Parekh | S. Nagpal | J. Abramson | R. Gaur | P. Caimi | M. Fanale | R. Little | A. Noy | M. Lechowicz | M. Roschewski | B. Kahl | D. Jagadeesh | J. Hayslip | C. Melani | A. Lucas | W. Wilson